ITTOF yields 2.25% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ITTOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ITTOF + PFE for your $10,000?
ITOCHU Techno-Solutions Corporation engages in the sale, maintenance, and support of computers and network systems, software development, information processing, and support services in Japan, rest of Asia, and internationally. It offers information services-related to science and engineering; system maintenance and support services, including assembly, transfer, and installation of equipment, as well as 24-hour maintenance and systems operation services; and IT engineer training services. The company also provides IT infrastructure, business operational systems, data center operation and management, and control/management of satellite communications systems; ERP-related software development and maintenance services; satellite communications and broadcasting operation services; cloud services; and application development services. In addition, it offers sale of network and security-related equipment, storage-related devices, and software and other peripheral devices, as well as provision of IT consulting, deployment/building, and support services; and building facility operations management activities for computer centers. Further, the company is involved in the exportation of IT products; resale of hardware and software; planning, production, and maintenance of web content; planning and production of advertising media; and information gathering, research, and marketing activities. It serves telecommunication, finance, retail and distribution, public sectors and utilities, manufacturing, healthcare and medicine, transportation, and information and communications industries, as well as educational and research institutions. The company was founded in 1972 and is headquartered in Tokyo, Japan. ITOCHU Techno-Solutions Corporation is a subsidiary of ITOCHU Corporation.
Full ITTOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.